Clinical trial
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
NCT01294228 is registered in ClinicalTrials.gov with Abbott RDx Cardiometabolic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
- Lead sponsor
- Abbott RDx Cardiometabolic
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 1,001 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.